4//SEC Filing
AVEO PHARMACEUTICALS INC 4
Accession 0001209191-15-003154
CIK 0001325879operating
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:30 PM ET
Size
9.4 KB
Accession
0001209191-15-003154
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Award
Stock Option (right to buy)
2015-01-06+100,000→ 100,000 totalExercise: $0.84Exp: 2025-01-06→ Common Stock (100,000 underlying) - Sale
Common Stock
2015-01-07$0.80/sh−519$415→ 17,581 total - Disposition to Issuer
Common Stock
2015-01-06−1,485→ 18,100 total
Footnotes (4)
- [F1]Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of an award of restricted stock granted to the reporting person on June 26, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
- [F3]The price reported in this Column 4 is an average price. The shares were sold in multiple transactions at prices ranging from $0.78 to $0.82, inclusive.
- [F4]This option vests in equal monthly installments from January 6, 2015 through January 6, 2019.
Documents
Issuer
AVEO PHARMACEUTICALS INC
CIK 0001325879
Entity typeoperating
Related Parties
1- filerCIK 0001325879
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:30 PM ET
- Size
- 9.4 KB